A Day Up For Prelude Therapeutics Incorporated
Tue, Aug 13, 2024 at 07:14 PM
Prelude Therapeutics Incorporated (PRLD:NASDAQ) shot up at $6.2, a gain of 30.5%. On Tue, Aug 13, 2024, PRLD:NASDAQ touched a New 2-Week Intraday Low of $4.7. The stock got featured on our News Catalysts scanner on Mon, Aug 12, 2024 at 02:03 PM in the 'EARNINGS' category. From Tue, Jul 30, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days
About Prelude Therapeutics Incorporated (PRLD:NASDAQ)
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with...
Top 10 Gainers:
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 175%
- Vicinity Motor Corp. (VEV:NASDAQ), 110.06%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 84.35%
- Lifeway Foods, Inc. (LWAY:NASDAQ), 48.62%
- Vinco Ventures Inc. (BBIG:NASDAQ), 42.86%
- Fenbo Holdings Limited (FEBO:NASDAQ), 39.21%
- iLearningEngines Holdings Inc Cl A (AILE:NASDAQ), 31.48%
- Fly-E Group Inc. (FLYE:NASDAQ), 31.21%
- GlucoTrack Inc. (GCTK:NASDAQ), 31.15%
- Prelude Therapeutics Incorporated (PRLD:NASDAQ), 30.53%